• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞样细胞在由对p53诱导的凋亡具有抗性的重组三阴性乳腺癌细胞群体进行侵袭和间充质转化过程中的作用

Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis.

作者信息

Inoue Sana, Imanishi Miki, Kanzaki Ai, Fujimoto Atsumi, Maeyama Marina, Okamoto Ayaka, Matsuda Hiroka, Yoshikawa Kiyotsugu, Takahashi Rei

机构信息

Graduate School of Pharmaceutical Sciences Doshisha Women's College of Liberal Arts, Kyoto, Japan.

Faculty of Pharmaceutical Sciences Doshisha Women's College of Liberal Arts, Kyoto, Japan.

出版信息

Acta Histochem Cytochem. 2022 Oct 28;55(5):169-184. doi: 10.1267/ahc.22-00076. Epub 2022 Oct 25.

DOI:10.1267/ahc.22-00076
PMID:36405550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9631983/
Abstract

We investigated the role of cancer stem cells (CSCs) in a population of triple-negative breast cancer (TNBC) cells that are resistant to apoptosis. A human breast cancer cell population capable of inducing p53 expression with doxycycline (Dox) was created and used as an untreated control (UT). After the addition of Dox to UT for 5 days, the cell population reconstituted with cells showing resistance to apoptosis was named RE. Fluorescence-activated cell sorting (FACS) and immunostaining revealed that after the addition of Dox, the ratio of cells in the S and G2/M phases decreased in UT as apoptosis proceeded, but did not markedly change in apoptosis-resistant RE. CSC-like cells in RE exhibited a cell morphology with a larger ratio of the major/minor axis than UT. FACS showed that RE had a higher proportion of CSC-like cells and contained more CD44CD24 mesenchymal CSCs than ALDH1A3 epithelial-like CSCs. In a Matrigel invasion assay, UT was more likely to form a three-dimensional cell population, whereas RE exhibited a planar population, higher migration ability, and the up-regulated expression of epithelial-mesenchymal transition-related genes. These results provide insights into the mechanisms by which TNBC cells acquire treatment resistance at the time of recurrence.

摘要

我们研究了癌症干细胞(CSCs)在一群对凋亡具有抗性的三阴性乳腺癌(TNBC)细胞中的作用。创建了一个能够用强力霉素(Dox)诱导p53表达的人乳腺癌细胞群体,并将其用作未处理对照(UT)。在向UT中添加Dox 5天后,用对凋亡具有抗性的细胞重建的细胞群体被命名为RE。荧光激活细胞分选(FACS)和免疫染色显示,添加Dox后,随着凋亡的进行,UT中处于S期和G2/M期的细胞比例下降,但在抗凋亡的RE中没有明显变化。RE中的CSC样细胞表现出一种细胞形态,其长轴与短轴的比例大于UT。FACS显示,RE中CSC样细胞的比例更高,并且包含更多的CD44CD24间充质CSC,而不是ALDH1A3上皮样CSC。在基质胶侵袭试验中,UT更有可能形成三维细胞群体,而RE表现出平面群体、更高的迁移能力以及上皮-间质转化相关基因的表达上调。这些结果为TNBC细胞在复发时获得治疗抗性的机制提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/206e7ceb9405/AHC22-00076f09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/76594ec4327d/AHC22-00076f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/17513a98a7ff/AHC22-00076f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/cfae390cca4e/AHC22-00076f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/005931ddf016/AHC22-00076f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/5b8ba455ea25/AHC22-00076f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/5e568412efa9/AHC22-00076f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/e19ff594b106/AHC22-00076f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/e5607d8ea6da/AHC22-00076f08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/206e7ceb9405/AHC22-00076f09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/76594ec4327d/AHC22-00076f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/17513a98a7ff/AHC22-00076f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/cfae390cca4e/AHC22-00076f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/005931ddf016/AHC22-00076f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/5b8ba455ea25/AHC22-00076f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/5e568412efa9/AHC22-00076f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/e19ff594b106/AHC22-00076f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/e5607d8ea6da/AHC22-00076f08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/9631983/206e7ceb9405/AHC22-00076f09.jpg

相似文献

1
Role of Cancer Stem-like Cells in the Process of Invasion and Mesenchymal Transformation by a Reconstituted Triple-negative Breast Cancer Cell Population Resistant to p53-induced Apoptosis.癌症干细胞样细胞在由对p53诱导的凋亡具有抗性的重组三阴性乳腺癌细胞群体进行侵袭和间充质转化过程中的作用
Acta Histochem Cytochem. 2022 Oct 28;55(5):169-184. doi: 10.1267/ahc.22-00076. Epub 2022 Oct 25.
2
Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.双重抑制 Wnt 和 Yes 相关蛋白信号通路可延缓间充质和上皮状态下三阴性乳腺癌的生长。
Mol Oncol. 2018 Apr;12(4):423-440. doi: 10.1002/1878-0261.12167. Epub 2018 Feb 21.
3
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.干扰素-β抑制三阴性乳腺癌中的癌症干细胞特性。
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797. doi: 10.1073/pnas.1713728114. Epub 2017 Dec 11.
4
Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.抑制Cdk2激酶活性可选择性地作用于CD44⁺/CD24⁻/Low干细胞样亚群,恢复SUM149PT三阴性乳腺癌细胞的化学敏感性。
Int J Oncol. 2014 Sep;45(3):1193-9. doi: 10.3892/ijo.2014.2523. Epub 2014 Jun 25.
5
Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.抑制表皮生长因子受体信号传导可增强乳腺癌干细胞的间充质-上皮转化及其对抗癌药物的反应性。
FEBS J. 2017 Jun;284(12):1830-1854. doi: 10.1111/febs.14084. Epub 2017 May 16.
6
Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.Stat3/Oct-4/c-Myc 信号通路调控三阴性乳腺癌干细胞多柔比星耐药及 WP1066 的抑制作用
Int J Oncol. 2018 Jul;53(1):339-348. doi: 10.3892/ijo.2018.4399. Epub 2018 May 8.
7
TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.TGF-β 通过调节干性、EMT 和细胞凋亡在三阴性乳腺癌(TNBC)耐药中发挥重要作用。
Biochem Biophys Res Commun. 2018 Jul 7;502(1):160-165. doi: 10.1016/j.bbrc.2018.05.139. Epub 2018 May 24.
8
Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.CD29 和 CD44 标志物富集的癌症干细胞样细胞在鳞状细胞癌中表现出具有上皮-间充质转化的分子特征。
Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28.
9
Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.PG11047 通过靶向多胺代谢途径减少假定的 CD44+CD24- 乳腺癌干细胞群体。
Anticancer Drugs. 2010 Nov;21(10):897-906. doi: 10.1097/CAD.0b013e32833f2f77.
10
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.鉴定与三阴性乳腺癌中 BET 抑制相关的干性相关基因谱。
Cell Oncol (Dordr). 2020 Jun;43(3):431-444. doi: 10.1007/s13402-020-00497-6. Epub 2020 Mar 12.

引用本文的文献

1
Cancer stem cell specificity as new targets in breast tumor treatment.癌症干细胞特异性作为乳腺肿瘤治疗的新靶点。
Oncol Res. 2025 Mar 19;33(4):811-819. doi: 10.32604/or.2024.050505. eCollection 2025.
2
Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor.内质网阴性乳腺癌中细胞质内质网的免疫定位作为一种有力的良好预后预测指标
Acta Histochem Cytochem. 2023 Aug 30;56(4):59-66. doi: 10.1267/ahc.23-00016. Epub 2023 Aug 23.

本文引用的文献

1
GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells.GTSE1 通过促进其核输出促进肝癌细胞中 SNAIL1 的降解。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12093. Epub 2021 Apr 21.
2
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.乳腺癌干细胞作为肿瘤化疗耐药、休眠和复发的驱动因素:新挑战与治疗机遇
Cancers (Basel). 2019 Oct 15;11(10):1569. doi: 10.3390/cancers11101569.
3
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
三阴性乳腺癌:当前认识与针对癌症干性的未来治疗突破
Cancers (Basel). 2019 Sep 9;11(9):1334. doi: 10.3390/cancers11091334.
4
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.三阴性乳腺癌化疗耐药的机制——我们如何应对挑战。
Cells. 2019 Aug 22;8(9):957. doi: 10.3390/cells8090957.
5
CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs.乳腺癌中的癌症干细胞——并非一概而论:靶向异质性上皮和间充质癌症干细胞的治疗进展
Cancers (Basel). 2019 Aug 7;11(8):1128. doi: 10.3390/cancers11081128.
6
Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.类干细胞样人乳腺癌细胞在基质胶上引发血管生成拟态。
Acta Histochem Cytochem. 2018 Dec 20;51(6):173-183. doi: 10.1267/ahc.18041. Epub 2018 Dec 15.
7
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.为了理解肿瘤微环境中的癌症干细胞异质性。
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):148-157. doi: 10.1073/pnas.1815345116. Epub 2018 Dec 26.
8
[Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].[组蛋白去乙酰化酶的抑制通过一种Slug介导的机制逆转三阴性乳腺癌细胞中的上皮-间质转化]
Mol Biol (Mosk). 2018 May-Jun;52(3):474-481. doi: 10.7868/S0026898418030102.
9
TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.TGF-β 通过调节干性、EMT 和细胞凋亡在三阴性乳腺癌(TNBC)耐药中发挥重要作用。
Biochem Biophys Res Commun. 2018 Jul 7;502(1):160-165. doi: 10.1016/j.bbrc.2018.05.139. Epub 2018 May 24.
10
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.干扰素-β抑制三阴性乳腺癌中的癌症干细胞特性。
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797. doi: 10.1073/pnas.1713728114. Epub 2017 Dec 11.